In the news

According to the CFIA, Aqua Blue Seafood Ltd. reported recalled Mowi brand Norwegian Atlantic Salmon – Cold Smoked (113g package), sold from March 27, 2024, to and including April 10, 2024, because it may allow the growth of Clostridium botulinum. There have been no reported illnesses associated with the consumption of this product. @ https://recalls-rappels.canada.ca/en/alert-recall/mowi-brand-norwegian-atlantic-salmon-cold-smoked-recalled-due-potential-presence?utm_source=gc-notify&utm_medium=email&utm_content=en&utm_campaign=hc-sc-rsa-22-23

The FDA reported that as of April 9, 2024, illnesses in a multi-year, multistate outbreak of Listeria monocytogenes infections linked to queso fresco and cotija cheeses manufactured by Rizo Lopez Foods, Inc., of Modesto, California is over. The CDC reports 26 cases in 11 states (AZ, CA, CO, FL, GA, NV, NC, OR, TN, TX, and WA). There have been a total of 23 hospitalizations, and two deaths were reported. The last illness onset date was December 10, 2023. The product was distributed Nationwide and in Canada. The FDA’s outbreak investigation is closed. The FDA has developed a prevention strategy to reduce outbreaks and illnesses of listeriosis associated with soft, fresh queso fresco cheeses. @ https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-listeria-monocytogenes-queso-fresco-and-cotija-cheese-february-2024?utm_medium=email&utm_source=govdelivery

CORE update of April 10, 2024: the CORE list of outbreaks and adverse events includes three activity cases. One new outbreak of Salmonella Typhimurium (ref# 1218) has been added to the table. The food source has not been identified. The FDA had initiated a traceback.@ https://www.fda.gov/food/outbreaks-foodborne-illness/investigations-foodborne-illness-outbreaks?utm_medium=email&utm_source=govdelivery

Astek Diagnostics, founded by Mustafa Al-Adhami, PhD, in response to his grandfather’s experience with a urinary tract infection (UTI), is on a mission to transform diagnostic procedures. Witnessing his grandfather’s suffering, Al-Adhami recognized the urgent need for a more efficient and precise diagnostic solution. Thus, he conceived the idea of the Jiddu Analyser, aimed at providing rapid antibiotic sensitivity testing within one hour. The company started in 2021 when Al-Adhami sketched his vision for a one-hour antibiotic sensitivity test. The Jiddu Analyzer streamlines the diagnostic process, offering rapid and precise results directly from patient samples at the point of care. Astek wants to alleviate patient discomfort, prevent complications, and improve overall healthcare outcomes by eliminating the need for guesswork and expediently identifying bacterial infections. @ https://femtechinsider.com/astek-diagnostics-uti-identification-treatment/